Stocktoria

Retrieve Medical Holdings, Inc. RMHI

OTC · stock · Pharmaceutical Preparations · website · IPO 2010-05-17

Retrieve Medical Holdings, Inc. financials (annual, from 10-K)

Revenue
2014201420152016201720182019202020212022
Net income
2014201420152016201720182019202020212022
Free cash flow
2014201420152016201720182019202020212022

Bars are annual figures from 2014 to 2022; red bars are negative (a loss or cash outflow).

MetricFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2014
R&D expense$13,051$30,000
SG&A expense$23,680$24,000
Operating income-$163,302-$68,721-$5,535-$5,684-$27,823-$44,987$1.1M-$2.3M-$956,876
Interest expense$32,081$10,397$9,476$8,309$5,584$1,240$0$2,202-$696,628$30,388
Income tax$0$0
Net income-$164,969-$76,089-$15,011-$13,993-$28,407-$51,227$1.2M-$2.3M-$3.8M-$962,614
Operating cash flow-$68,553-$14,256-$119-$1,743-$43,721-$18,313-$200,352-$247,589-$933,475-$577,492
Free cash flow-$200,352-$249,775
Cash & equivalents$0$0$0$0$451,431$118,018
Total assets$130,349$261,152$408$527$2,270$2,991$1,304$281,370$490,908$146,888
Total liabilities$621,503$587,337$250,504$235,612$223,362$195,676$142,762$288,632$54,427$675,646
Shareholders' equity-$491,154-$326,185-$250,096-$235,085-$221,092-$192,685-$141,458-$7,262$436,481-$528,758

Growth · year-over-year

MetricFY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014FY2014
Net income growth-104.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Source: SEC EDGAR filings · CIK 0001452804 · US · as of 2022-09-30. facts plus Stocktoria's own computed scores — not investment advice.